Cannabics Pharmaceuticals prices $7.5M in registered direct offering

Rockville-based Cannabics Pharmaceuticals Inc. raised $7.5 million Monday through the sale of 10 million shares of common stock to investors and warrants to purchase up to 5 million shares of common stock at a combined offering price of $0.75 per share and warrant, pursuant to a registered direct offering. The warrants will have an exercise price of $1.00 per share, ...

To purchase a reprint of this article, contact reprints@thedailyrecord.com.

Leave a Reply

Your email address will not be published. Required fields are marked *